Ausgabe 1/2000
Inhalt (13 Artikel)
Lipid modulation and atherosclerotic events: Extending the clinical spectrum with fibrates and statins
Evan A. Stein
Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?
Agostino Faggiotto, Rodolfo Paoletti
Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk
MacRae F. Linton, Sergio Fazio
Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol
Patrick H. Bowen, John R. Guyton
Niacin dosing: Relationship to benefits and adverse effects
David M. Capuzzi, John M. Morgan, Osvaldo A. Brusco Jr., Charles M. Intenzo